Fangtaida Biomedical Technology Co., Ltd., invested by fangtaida biomedical technology (Beijing) Co., Ltd., a wholly-owned company of frontida biopharm, Inc., with a registered capital of 50 million *, has built a 2800 square meter Pharmaceutical Research Laboratory for API pharmaceutical research, formulation process and analysis method development of new drugs and generic drugs in Zhengdong New Area, Zhengzhou, Henan Province. The focus of domestic business development is to serve the Chinese market with international pharmaceutical R & D quality, help Chinese pharmaceutical enterprises go global, develop API and preparation products for the Chinese market with international R & D quality, and provide API process development, quality research, formulation process R & D services, analytic..